PDCD1 and neoplasm: Myeloid-PD-1-knockout was superior to systemic PD-1-knockdout and T-cell PD-1 conditional knockout for tumor inhibition, even in MC38 tumors where T-cells PD-1 knockout functioned slightly but myeloid-PD-1 deletion completely inhibited MC38 growth.